45 patients wih degenerative joint diseases ( osteoarthrosis of the hip or knee , heberden 's nodes ) were treated for 5 weeks in an open controlled trial with sulindac , a new nonsteroidal antirheumatic drug ( 300-400 mg daily ) .
C0029408
degenerative joint diseases
C0038792
sulindac